SAPD
Sociedad Andaluza
de
Patología Digestiva
Iniciar sesión
Buscar en la RAPD Online
This work is licensed under

CC BY-NC-ND 4.0
RAPD 2024
VOL 47
N4 Julio - Agosto 2024

N4 July - August 2024
PDF

Datos de la publicación


Early stenosis and dehiscence of surgical esophago-jejunal anastomosis treated with different endoscopic techniques


Abstract

Benign esophageal stenosis is a common pathology in daily clinical practice. Most cases are simple and are successfully treated with endoscopic dilation (ED) using bougies or balloons. In recurrent or refractory stenosis cases, other endoscopic options should be considered, with incisional therapy (IT) being deemed an effective and safe alternative.

We report a case of a patient with chronic gastritis, extensive multifocal intestinal metaplasia, and high-grade dysplasia in the antrum and body without visible lesions. The patient underwent total gastrectomy with Roux-en-Y reconstruction and subsequently developed early stenosis of the anastomosis, necessitating dilation with bougies, stent placement, and incisional therapy.

Keywords: anastomotic stenosis, dilation, incisional therapy.


CORRESPONDENCIA

María Fernández Mascuñano

Virgen Macarena University Hospital. Seville.

41009 Sevilla

mariaviso96@gmail.com

CITA ESTE TRABAJO

González Parra AC, Fernández Mascuñano M, Muñoz García-Borruel M, Rodríguez-Téllez M. Early stenosis and dehiscence of surgical esophago-jejunal anastomosis treated with different endoscopic techniques. RAPD 2024;47(4):152-155. DOI: 10.37352/2024474.2

Introduction

There are a number of well-described gastrointestinal complications following Roux-en-Y gastrectomy. One of these is stricture of the anastomosis, described in 5-46% of cases of oesophagogastric surgery[1].

Most oesophageal strictures are simple and are associated with good response to endoscopic therapy with dilatation. However, up to 10-30% of strictures may become complex, leading to increased refractoriness and the need for repeated therapies. In cases where conventional endoscopic dilatation is not sufficient, IT is positioned as a considerable alternative for refractory benign strictures[1],[2],[4].

However, such techniques are not without risk, with perforation being the most frequent complication (0.1-0.6% with ED and about 5.6% with IT), which is usually resolved endoscopically with prosthesis placement [2],[3].

Clinical case

A 66-year-old woman with no personal or family history of interest. She consulted for dyspepsia, and an upper endoscopy (EGD) was requested, which revealed chronic gastritis with extensive multifocal metaplasia and high-grade dysplasia in the antrum and body with no visible lesions (Figure 1). The case was discussed in a multidisciplinary committee and a decision was made to perform a laparoscopic total gastrectomy with Roux-en-Y reconstruction, which was performed without early complications. Two months later, the patient developed almost complete dysphagia, so a new EGD was performed, and punctiform stenosis of the anastomosis was observed (Figure 2). It was decided to dilate the anastomosis with 8 to 12 mm Savary-Gilliard bougies (Figure 3), resulting in immediate dehiscence of the anastomosis, which required the placement of a coated metal prosthesis (UltraflexTM 120 x 23 mm) (Figures 4 & 5). Subsequent evolution was satisfactory, and the prosthesis could be removed after one month.

Figure 1

NBI endoscopic image of the areas of intestinal metaplasia in the gastric body.

imagenes/cc1_fig1.jpg
Figure 2

Endoscopic view of punctiform stricture of the oesophago-jejunal anastomosis.

imagenes/cc1_fig2.jpg
Figure 3

Endoscopic view of the stenosis, showing the canulotome through where the guides where bougies will pass through are introduced.

imagenes/cc1_fig3.jpg
Figure 4

Endoscopic view of the coated metal prosthesis (UltraflexTM 120 x 23 mm).

imagenes/cc1_fig4.jpg
Figure 5

Normopositioned prosthesis, radiological vision.

imagenes/cc1_fig5.jpg

Six months after the procedure, the patient again reported dysphagia, and EGD was performed and identified recurrence of the stricture, which was treated with IT following the standard technique, using the IT nano scalpel and adding intralesional triamcinolone. The procedure was performed without immediate complications and the patient was discharged after 24 hours and remained asymptomatic after three months.

Discussion

Early stricture of the oesophago-jejunal anastomosis is a known complication after surgery. Endoscopic therapy is the treatment of choice for benign strictures when symptomatic, with balloon or bougie dilatation, incisional therapy or prosthesis placement being the most common options.

The ED technique is carried out by means of bougies or balloon. The first technique is based on dilatation by application of combined radial and longitudinal force, which can be performed under fluoroscopic control. The balloon, on the other hand, applies only radial force, and has the advantage of allowing direct endoscopic visualisation[1],[2].

A systematic review published in 2018 concluded that both techniques are equivalent in terms of effectiveness and safety, with no differences in clinical outcomes, recurrence at twelve months, bleeding and perforation rate. Therefore, the choice of one technique or the other should be based on the experience of the endoscopist and the availability at each centre[3].

The goal of IT is resection of the fibrotic ring. Typical strictures to be treated with this technique are those that are benign, short (1-2 cm) and formed by fibrocycatricial tissue. There are two modalities, the radial incision and the circumferential incision, in which the fibrotic area is resected circumferentially following the axial axis of the oesophagus. The most frequent adverse effects (AE) are pain, bleeding and perforation, with the rate of AE being very low and similar to those of ED[1].

There is a randomised clinical trial comparing 62 patients with anastomotic stenosis, those treated with bougies and those treated with IT. There is no significant difference in both groups in either clinical success or AE rate[5]. However, Muto et al. published a retrospective cohort study comparing the efficacy of IT with ED in 54 patients with surgical oesophago-gastric stricture, concluding that there was superiority in oesophageal patency at 6 and 12 months in IT treatment over ED (65.3% vs 19.8%, p<0.005; 61.5% vs 19.8%, p<0.005)[6]. Therefore, the choice of ED or IT is controversial, prospective studies with larger sample numbers and longer term are required to draw conclusions. It seems reasonable to conclude that IT is an alternative to ED when performed by trained personnel and in short anastomotic strictures[2].

Regarding corticosteroid injection, while pre-procedure administration has not shown benefit, the addition of intralesional triamcinolone following dilatation of a post-surgical stricture statistically significantly reduces the number of procedures required to resolve the stricture, with clinical improvement of symptoms[7],[8].

On the other hand, the European Society of Gastrointestinal Endoscopy (ESGE) is against their first-line use in benign strictures due to the potential increase in AEs, such as migration or epithelial hyperplasia that makes their removal difficult, relegating their indication to the failure of previous treatments. Prostheses are indicated as first-line palliative treatment for malignant strictures or for the resolution of leaks or perforations[3],[9].

We can conclude that in some cases strictures of oesophago-gastric surgical anastomoses are challenging to manage due to their refractoriness. In these cases, endoscopic balloon or bougie dilatation and incisional therapy are effective and safe options if performed by trained staff. However, it is not a risk-free process, with perforation being the most frequent and serious complication, which is also usually resolved with endoscopic treatment, as in our case.

Bibliografía

1 

Merino Gallego E, Martínez Amate E, Gallego Rojo FJ. Incisional endoscopic therapy as a therapeutic alternative in esophageal anastomotic strictures refractory to conventional treatment. Rev Esp Enferm Dig. 2019 Sep;111(9):717-719.

2 

Fugazza A, Repici A. Endoscopic Management of Refractory Benign Esophageal Strictures. Dysphagia. 2021 Jun;36(3):504-516.

3 

Josino IR, Madruga-Neto AC, Ribeiro IB, Guedes HG, Brunaldi VO, de Moura DTH, Bernardo WM, de Moura EGH. Endoscopic Dilation with Bougies versus Balloon Dilation in Esophageal Benign Strictures: Systematic Review and Meta-Analysis. Gastroenterol Res Pract. 2018 Jul 15.

4 

Iersema PD. Wijkerslooth LR. Dilatation of refractory benign esophageal strictures. Gastrointest Endosc 2009;70:1000-12.

5 

Hordijk ML, van Hooft JE, Hansen BE, Fockens P, Kuipers EJ. A randomized comparison of electrocautery incision with Savary bougienage for relief of anastomotic gastroesophageal strictures. Gastrointest Endosc. 2009 Nov;70(5):849-55.

6 

Muto M, Ezoe Y, Yano T, Aoyama I, Yoda Y, Minashi K, Morita S, Horimatsu T, Miyamoto S, Ohtsu A, Chiba T. Usefulness of endoscopic radial incision and cutting method for refractory esophagogastric anastomotic stricture (with video). Gastrointest Endosc. 2012 May;75(5):965-72.

7 

Hirdes MM, van Hooft JE, Koornstra JJ, Timmer R, Leenders M, Weersma RK, Weusten BL, van Hillegersberg R, van Berge Henegouwen MI, Plukker JT, Wiezer R, Bergman JG, Vleggaar FP, Fockens P, Siersema PD. Endoscopic corticosteroid injections do not reduce dysphagia after endoscopic dilation therapy in patients with benign esophagogastric anastomotic strictures. Clin Gastroenterol Hepatol. 2013 Jul;11(7):795-801.

8 

Dasari CS, Jegadeesan R, Patel HK, Desai M, Aziz M, Thoguluvachandrasekar V, Duvvuri A, Kohli DR, Repici A, Siersema PD, Sharma P. Intralesional steroids and endoscopic dilation for anastomotic strictures after esophagectomy: systematic review and meta-analysis. Endoscopy. 2020 Sep;52(9):721-726.

9 

Spaander MCW, van der Bogt RD, Baron TH, Albers D, Blero D, de Ceglie A, Conio M, Czakó L, Everett S, Garcia-Pagán JC, Ginès A,Jovani M, Repici A, Rodrigues-Pinto E, Siersema PD, Fuccio L, van Hooft JE. Esophageal stenting for benign and malignant disease: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2021. Endoscopy. 2021 Jul;53(7):751-762.